Regulation & Compliance

National Bank's integration of CWB Wealth sparks fund terminations and a major shift in strategy, forcing investors to make critical financial decisions.

Thorne released impressive consumer data for its supplements. But what do these studies really mean for consumers in a crowded, unregulated market?

The fintech pioneer just launched an AI-powered advisor. Here's how it plans to change the way you manage money and reshape the entire industry.

Aon's successful stablecoin trial marks a turning point for insurance, promising faster, cheaper payments fueled by new regulations and technology.

Streaming service Arena Radio challenges the industry by segregating AI music, denying it royalties, and championing a new 'pro-human' economic model.

iWrity promises to solve the indie author review crisis with a mutual support system. We investigate if this new tool is a breakthrough or a risk to authors.

At HIMSS26, Juno Health debuts its v25 EHR, leveraging AI, integrated RCM, and true interoperability to tackle clinician burnout and data silos.

With foundational patents and a focus on compliance, Bitcoin Bancorp aims to put secure crypto ATMs in convenience stores. Can they win over investors?

Smartria launches SmartReview and SmartAssist, new AI tools for RIAs, promising to streamline compliance while navigating complex security and regulatory hurdles.

Healthcare tech firm Marpai secures a massive marketing deal, gaining potential access to 1.5 million employees for its transparent pharmacy benefit platform.

Backed by Chicago Ventures, ILS aims to eliminate tedious manual tasks for investment lawyers with its fast-growing AI-powered side letter platform.

A new joint venture in Ohio aims to build a domestic HALEU supply chain, promising to unlock advanced nuclear energy and revitalize a local economy.

Clearsense unveils its AI strategy at HIMSS 2026, aiming to cut costs and transform passive data archives into active intelligence hubs for healthcare.

FinVolution Group is set to release its 2025 financials, with investors watching to see if international growth and AI tech can navigate market headwinds.

With a historic $2B Series C and a $14.6B valuation, Nscale is escalating the global race to build the power grid for the AI revolution.

A new trial in China tests a dual-action antibody for esophageal cancer, a top killer. The therapy aims to unleash a two-pronged immune attack on tumors.

Global investment giant H.I.G. Capital adopts ToltIQ's AI platform, signaling a major shift in how private equity firms evaluate deals and manage risk.

A Cayman firm's three award nominations highlight a pivotal shift as institutional investors seek regulated, turnkey platforms to safely enter digital assets.

A Knights of Columbus convoy braved icy roads to bring record-breaking aid to a remote First Nations community recovering from devastating wildfires.

DraftKings and ESPN launch account linking ahead of March Madness, offering a hyper-personalized betting experience that blurs lines between content and gaming.